Merck Signs Wide-Ranging MOU To Help Beef Up Korea's Global R&D Capabilities
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Merck & Co. Inc. has signed a memorandum of understanding with South Korea to invest KRW 210 billion ($192.9 million) in the country for research and development of new drugs, including manpower exchanges, Korea's Ministry of Health and Welfare said